Literature DB >> 25964877

Key role of human leukocyte antigen in modulating human immunodeficiency virus progression: An overview of the possible applications.

Alba Grifoni1, Carla Montesano1, Vittorio Colizzi1, Massimo Amicosante1.   

Abstract

Host and viral factors deeply influence the human immunodeficiency virus (HIV) disease progression. Among them human leukocyte antigen (HLA) locus plays a key role at different levels. In fact, genes of the HLA locus have shown the peculiar capability to modulate both innate and adaptive immune responses. In particular, HLA class I molecules are recognized by CD8(+) T-cells and natural killers (NK) cells towards the interaction with T cell receptor (TCR) and Killer Immunoglobulin Receptor (KIR) 3DL1 respectively. Polymorphisms within the different HLA alleles generate structural changes in HLA class I peptide-binding pockets. Amino acid changes in the peptide-binding pocket lead to the presentation of a different set of peptides to T and NK cells. This review summarizes the role of HLA in HIV progression toward acquired immunodeficiency disease syndrome and its receptors. Recently, many studies have been focused on determining the HLA binding-peptides. The novel use of immune-informatics tools, from the prediction of the HLA-bound peptides to the modification of the HLA-receptor complexes, is considered. A better knowledge of HLA peptide presentation and recognition are allowing new strategies for immune response manipulation to be applied against HIV virus.

Entities:  

Keywords:  CD8+ T lymphocytes; Epitope; Human immunodeficiency virus progression; Human leukocyte antigen; Immunoinformatics

Year:  2015        PMID: 25964877      PMCID: PMC4419116          DOI: 10.5501/wjv.v4.i2.124

Source DB:  PubMed          Journal:  World J Virol        ISSN: 2220-3249


  83 in total

Review 1.  Cellular immune responses to HIV.

Authors:  A J McMichael; S L Rowland-Jones
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

2.  Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.

Authors:  Geraldine M O'Connor; Kieran J Guinan; Rodat T Cunningham; Derek Middleton; Peter Parham; Clair M Gardiner
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

Review 3.  Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.

Authors:  Peter Parham; Paul J Norman; Laurent Abi-Rached; Lisbeth A Guethlein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

4.  Different selection patterns of resistance and cross-resistance to HIV-1 agents targeting CCR5.

Authors:  Mercedes Armand-Ugón; Gemma Moncunill; Emmanuel Gonzalez; MariaPau Mena; Ester Ballana; Bonaventura Clotet; José A Esté
Journal:  J Antimicrob Chemother       Date:  2010-01-12       Impact factor: 5.790

5.  Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.

Authors:  Geraldine M O'Connor; Julian P Vivian; Jacqueline M Widjaja; John S Bridgeman; Emma Gostick; Bernard A P Lafont; Stephen K Anderson; David A Price; Andrew G Brooks; Jamie Rossjohn; Daniel W McVicar
Journal:  J Immunol       Date:  2014-02-21       Impact factor: 5.422

6.  Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach.

Authors:  Anne S De Groot; Bill Jesdale; William Martin; Caitlin Saint Aubin; Hakima Sbai; Andrew Bosma; Judy Lieberman; Gail Skowron; Fadi Mansourati; Kenneth H Mayer
Journal:  Vaccine       Date:  2003-10-01       Impact factor: 3.641

7.  CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users.

Authors:  Kristi Huik; Maarja Sadam; Tõnis Karki; Radko Avi; Tõnu Krispin; Piret Paap; Kristi Rüütel; Anneli Uusküla; Ave Talu; Katri Abel-Ollo; Irja Lutsar
Journal:  J Infect Dis       Date:  2010-03       Impact factor: 5.226

8.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615

Review 9.  Introduction and immunopathogenesis of acquired immune deficiency syndrome.

Authors:  S Sudharshan; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2008 Sep-Oct       Impact factor: 1.848

10.  MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy.

Authors:  Saif Ullah Munshi; Harekrushna Panda; Prasida Holla; Bharat Bhushan Rewari; Shahid Jameel
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

View more
  3 in total

1.  Phenome-wide association study maps new diseases to the human major histocompatibility complex region.

Authors:  Jixia Liu; Zhan Ye; John G Mayer; Brian A Hoch; Clayton Green; Loren Rolak; Christopher Cold; Seik-Soon Khor; Xiuwen Zheng; Taku Miyagawa; Katsushi Tokunaga; Murray H Brilliant; Scott J Hebbring
Journal:  J Med Genet       Date:  2016-06-10       Impact factor: 6.318

Review 2.  The Emerging Roles of Human Leukocyte Antigen-F in Immune Modulation and Viral Infection.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

3.  Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?

Authors:  Nicole Nourié; Hussein Nassereddine; Sarah Mouawad; Louaa Chebbou; Rita Ghaleb; Fatmeh Abbas; Hiba Azar
Journal:  BMC Nephrol       Date:  2022-03-05       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.